GEN1047 for Solid Tumors - First in Human (FIH) Trial
Genmab
Genmab
Genmab
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
AstraZeneca
Terremoto Biosciences Inc.
Ensem Therapeutics
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Eli Lilly and Company
Genmab
AstraZeneca
DualityBio Inc.
Second Life Therapeutics
Tanabe Pharma America, Inc.
Avenzo Therapeutics, Inc.
Volastra Therapeutics, Inc.
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Incyte Corporation
Cancer Research UK
NuCana plc
Hutchmed
Medicenna Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Klus Pharma Inc.
Esperas Pharma Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Mundipharma Research Limited
NovaOnco Therapeutics Co., Ltd.
Innolake Biopharm
NextCure, Inc.
Incyte Corporation
Incyte Corporation
Incyte Corporation
Gilead Sciences
Novartis
Incyte Corporation
NKGen Biotech, Inc.
Lumos Pharma
Petra Pharma
Poveda, Andrés, M.D.
Otsuka Novel Products GmbH
Arno Therapeutics
National Cancer Institute (NCI)